| Seliciclib | IC50 | 160.0 [1], 1069.0 [2] |
| Dinaciclib | IC50 | 1.0 [1], 45.0 [2] |
| 6-Bromoindirubin-3'-oxime | IC50 | 83.0 [1], 85.0 [2] |
| Olomoucine | IC50 | 3000.0 [1] |
| 7-Bromo-3-[3-(hydroxyamino)-1H-indol-2-yl]indol-2-one | IC50 | 10000.0 [1], 33000.0 [2] |
| Tofacitinib | IC50 | 10000.0 [1] |
| 2-[[9-(1-Methylethyl)-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-1-butanol | IC50 | 160.0 [1] |
| Palbociclib | IC50 | 10000.0 [1] |
| N-(4-Methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-YL)urea | IC50 | 100000.0 [1] |
| Alsterpaullone | IC50 | 40.0 [1] |
| Sulfuretin | IC50 | 1500.0 [1] |
| (3Z)-3-(1H-Imidazol-5-ylmethylene)-5-methoxy-1H-indol-2(3H)-one | IC50 | 65.0 [1] |
| Hymenialdisine | IC50 | 30.0 [1] |
| 4-({5-Amino-1-[(2,6-Difluorophenyl)carbonyl]-1h-1,2,4-Triazol-3-Yl}amino)benzenesulfonamide | IC50 | 12.59 [1] |
| 2-(Pyridin-4-yl)-6,7-dihydro-1H-pyrrolo[3,2-c]pyridin-4(5H)-one | IC50 | 460.0 [1] |
| 6-O-Cyclohexylmethyl guanine | IC50 | 97000.0 [1] |
| (16E)-14-Methyl-20-oxa-5,7,14,27-tetrazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(25),2(27),3,5,8,10,12(26),16,21,23-decaene | IC50 | 3.0 [1] |
| O6-Cyclohexylmethoxy-2-(4'-sulphamoylanilino) purine | IC50 | 480.0 [1] |
| BS-181 | IC50 | 3700.0 [1] |
| Aigialomycin D | IC50 | 6000.0 [1] |
| 3-(2-Aminopyrimidin-4-yl)-1H-indol-4-ol | IC50 | 3500.0 [1] |
| JNK Inhibitor VIII | Ki | 9300.0 [1] |
| 4-Methyl-3-(2-((2-morpholinoethyl)amino)quinazolin-6-yl)-N-(3-(trifluoromethyl)phenyl)benzamide | IC50 | 25000.0 [1] |
| Pyrimidone, 22 | IC50 | 100000.0 [1] |
| 2-(4-Fluoroanilino)-5-[3-fluoro-4-[6-methoxy-7-(3-morpholin-4-ylpropoxy)quinolin-4-yl]oxyphenyl]-3-methylpyrimidin-4-one | IC50 | 100000.0 [1] |
| (2R)-2-({9-(1-Methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol | IC50 | 225.0 [1] |
| 4-[[6-(Ethylamino)-2-[[1-(phenylmethyl)-5-indolyl]amino]-4-pyrimidinyl]amino]-1-cyclohexanol | IC50 | 25000.0 [1] |
| Palinurin | IC50 | 25000.0 [1] |
| N-(3-Cyclopropyl-1H-pyrazol-5-YL)-2-(2-naphthyl)acetamide | IC50 | 114.0 [1] |
| 7-Bromo-1-methyl-3-(3-nitroso-1H-indol-2-yl)indol-2-ol | IC50 | 10000.0 [1] |
| 6,11-Dihydroxy-3,3-dimethyl-12H-pyrano[2,3-c]acridin-7-one | IC50 | 10000.0 [1] |
| N-(4-Amino-5-cyano-6-ethoxypyridin-2-yl)acetamide | Ki | 9300.0 [1] |
| Lck Inhibitor | IC50 | 10000.0 [1] |
| 2-(7-Bromo-2-hydroxy-1H-indol-3-yl)-3-nitroso-1H-indole-6-carboxylic acid | IC50 | 10000.0 [1] |
| 2-(7-Bromo-2-hydroxy-1H-indol-3-yl)-5-[(E)-hydroxyiminomethyl]indol-3-one | IC50 | 200.0 [1] |
| 3-(3-Nitroso-1H-indol-2-yl)-7-(trifluoromethyl)-1H-indol-2-ol | IC50 | 10000.0 [1] |
| Methyl 2-(7-bromo-2-hydroxy-1H-indol-3-yl)-3-nitroso-1H-indole-5-carboxylate | IC50 | 10000.0 [1] |
| 4-Amino-5-chloro-6-ethoxy-pyridine-2-carboxylic acid 4-methanesulfonyl-benzylamide | Ki | 9300.0 [1] |
| 7-Chloro-3-oxo-8-(1,3-thiazol-5-ylmethylamino)-11,16-dioxa-2,4,19,21-tetrazatricyclo[15.3.1.05,10]henicosa-1(20),5,7,9,17(21),18-hexaene-18-carbonitrile | Ki | 9275.0 [1] |
| 1-[6-(4-Methoxybenzylamino)-9-isopropyl-9H-purine-2-yl]-3-methyl-1-pentyne-3-ol | IC50 | 400.0 [1] |
| C-2 Alkynylated purine deriv. 2c | IC50 | 340.0 [1] |
| C-2 Alkynylated purine deriv. 4e | IC50 | 230.0 [1] |
| 3-[2-(Pyridin-4-yl)-1,3-thiazol-4-yl]-1,2-dihydroquinolin-2-one | IC50 | 54.0 [1] |
| 3-(3,4-Dimethoxyphenyl)pyrrolo[2,3-b]pyrrolizin-8(1H)-one | IC50 | 50000.0 [1] |
| 3-(3,4-Dimethoxy-phenyl)-furo[2,3-b]pyrrolizin-8-one | IC50 | 50000.0 [1] |
| N-(4-Amino-5-cyano-6-ethoxypyridin-2-yl)-2-(2,5-dimethoxy-4-methylsulfonylphenyl)acetamide | Ki | 9300.0 [1] |
| N-(4-Amino-5-chloro-6-ethoxypyridin-2-yl)-2-(4-methanesulfonyl-2,5-dimethoxyphenyl)acetamide | Ki | 9300.0 [1] |
| N-(4-Amino-5-cyano-6-isopropoxypyridin-2-yl)-2-(4-methanesulfonyl-2,5-dimethoxyphenyl)acetamide | Ki | 9300.0 [1] |
| N-(4-Amino-5-cyano-6-phenylpyridin-2-yl)acetamide | Ki | 9300.0 [1] |
| 3-[2-(Pyridin-4-yl)-1,3-thiazol-4-yl]-1,2,3,4-tetrahydroquinazolin-2-one | IC50 | 79.0 [1] |
| Acylsemicarbazide deriv. 3aa | IC50 | 5.0 [1] |
| 2-(7-Bromo-2-hydroxy-1-methylindol-3-yl)indol-3-one | IC50 | 10000.0 [1] |
| (2z,3e)-7'-Bromo-3-(Hydroxyimino)-2'-Oxo-1,1',2',3-Tetrahydro-2,3'-Biindole-5-Carboxylic Acid | IC50 | 10000.0 [1] |
| 2-[2-Hydroxy-7-(trifluoromethyl)-1H-indol-3-yl]-3-nitroso-1H-indole-5-carbonitrile | IC50 | 10000.0 [1] |
| Methyl 2-(7-bromo-2-hydroxy-1H-indol-3-yl)-3-oxoindole-5-carboxylate | IC50 | 10000.0 [1] |
| Methyl 2-[2-hydroxy-7-(trifluoromethyl)-1H-indol-3-yl]-3-oxoindole-5-carboxylate | IC50 | 10000.0 [1] |
| 2-[2-Hydroxy-7-(trifluoromethyl)-1H-indol-3-yl]-3-oxoindole-5-carbonitrile | IC50 | 10000.0 [1] |
| Methyl 2-(7-bromo-2-hydroxy-1-methylindol-3-yl)-3-oxoindole-5-carboxylate | IC50 | 10000.0 [1] |
| Methyl 2-(7-bromo-2-hydroxy-1H-indol-3-yl)-3-oxoindole-6-carboxylate | IC50 | 10000.0 [1] |
| Methyl 2-[2-hydroxy-7-(trifluoromethyl)-1H-indol-3-yl]-3-oxoindole-6-carboxylate | IC50 | 10000.0 [1] |
| 2-(7-Bromo-2-hydroxy-1H-indol-3-yl)-3-oxoindole-6-carboxylic acid | IC50 | 10000.0 [1] |
| 2-(2-Hydroxy-1H-indol-3-yl)-3-nitroso-1H-indole-5-carboxylic acid | IC50 | 530.0 [1] |
| Methyl 2-[2-hydroxy-7-(trifluoromethyl)-1H-indol-3-yl]-3-nitroso-1H-indole-5-carboxylate | IC50 | 10000.0 [1] |
| 2-[2-Hydroxy-7-(trifluoromethyl)-1H-indol-3-yl]-3-nitroso-1H-indole-5-carboxylic acid | IC50 | 1600.0 [1] |
| Methyl 2-(7-bromo-2-hydroxy-1H-indol-3-yl)-3-nitroso-1H-indole-6-carboxylate | IC50 | 10000.0 [1] |
| Methyl 2-[2-hydroxy-7-(trifluoromethyl)-1H-indol-3-yl]-3-nitroso-1H-indole-6-carboxylate | IC50 | 1700.0 [1] |
| 2-[2-Hydroxy-7-(trifluoromethyl)-1H-indol-3-yl]-3-nitroso-1H-indole-6-carboxylic acid | IC50 | 3100.0 [1] |
| 2-(2-Hydroxy-1H-indol-3-yl)-3-oxoindole-5-carboxylic acid | IC50 | 3400.0 [1] |
| 2-[2-Hydroxy-7-(trifluoromethyl)-1H-indol-3-yl]-5-(2H-tetrazol-5-yl)indol-3-one | IC50 | 10000.0 [1] |
| 3-[3-Nitroso-5-(2H-tetrazol-5-yl)-1H-indol-2-yl]-7-(trifluoromethyl)-1H-indol-2-ol | IC50 | 10000.0 [1] |
| 4-Methyl-3-[2-(methylamino)quinazolin-6-yl]-N-[2-(1-methylpiperidin-4-yl)oxy-5-(trifluoromethyl)phenyl]benzamide | IC50 | 25000.0 [1] |
| N-[2-[3-(Dimethylamino)propyl-methylamino]-5-(trifluoromethyl)phenyl]-2-fluoro-5-[3-[4-(methylamino)-1,3,5-triazin-2-yl]pyridin-2-yl]oxybenzamide | IC50 | 100000.0 [1] |
| 3-[[[5-[1-(4-Methoxyphenyl)-1H-benzimidazol-6-yl]-1,3,4-oxadiazol-2-yl]thio]methyl]benzonitrile | IC50 | 10000.0 [1] |
| N-(5-Isopropyl-thiazol-2-yl)-isobutyramide | IC50 | 321.0 [1] |
| N-(5-(2-(Cyclohexyloxy)pyrimidin-4-yl)thiazol-2-yl)pyridin-2-amine | IC50 | 34.0 [1] |
| 5-(2-Amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-tert-butylpyridine-3-sulfonamide | IC50 | 10000.0 [1] |
| N-[3-[5-[2-(3-Morpholin-4-ylanilino)pyrimidin-4-yl]imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]-2-phenylacetamide | IC50 | 1000.0 [1] |
| 4-(4-Fluorophenyl)-N-[4-[3-[2-(methylamino)pyrimidin-4-yl]pyridin-2-yl]oxyphenyl]phthalazin-1-amine | IC50 | 25000.0 [1] |
| 6-Chloro-2-iodo-9-isopropyl-9H-purine | IC50 | 100000.0 [1] |
| C-2 Alkynylated purine deriv. 4d | IC50 | 500.0 [1] |
| C-2 Alkynylated purine deriv. 4f | IC50 | 300.0 [1] |
| C-2 Alkynylated purine deriv. 4g | IC50 | 600.0 [1] |
| C-2 Alkynylated purine deriv. 4h | IC50 | 260.0 [1] |
| C-2 Alkynylated purine deriv. 5a | IC50 | 300.0 [1] |
| C-2 Alkynylated purine deriv. 5b | IC50 | 300.0 [1] |
| C-2 Alkynylated purine deriv. 5c | IC50 | 400.0 [1] |
| C-2 Alkynylated purine deriv. 5d | IC50 | 500.0 [1] |
| C-2 Alkynylated purine deriv. 5e | IC50 | 500.0 [1] |
| 5,17-Dihydroxy-4,4,10,10,15-pentamethyl-3,9-dioxa-15-azapentacyclo[12.8.0.02,7.08,13.016,21]docosa-1,5,7,11,13,16(21),17,19-octaen-22-one | IC50 | 10000.0 [1] |
| 1-(5-Cyclobutyl-2-thiazolyl)-3-(5-isoquinolyl)urea | IC50 | 8.0 [1] |
| N-(5-Cyclobutyl-thiazol-2-yl)-2-phenyl-acetamide | IC50 | 25.0 [1] |
| N-(5-Cyclobutyl-thiazol-2-yl)-2-(2-methyl-benzothiazol-6-yl)-acetamide | IC50 | 12.0 [1] |
| 8-(Trifluoromethyl)-11H-indolo[3,2-c]quinoline-6-carboxylic acid | IC50 | 10000.0 [1] |
| 11H-Indolo[3,2-c]quinoline-6,8-dicarboxylic acid | IC50 | 10000.0 [1] |
| N-(5-Cyclobutyl-thiazol-2-yl)-2-isoquinolin-5-yl-acetamide | IC50 | 13.0 [1] |
| N-(5-Cyclobutyl-thiazol-2-yl)-2-(5,6-dimethyl-benzoimidazol-1-yl)-acetamide | IC50 | 13.0 [1] |
| Ethyl 2-methyl-6-oxo-5-(2-(pyridin-4-yl)thiazol-4-yl)-1,6-dihydropyridine-3-carboxylate | IC50 | 131.0 [1] |
| 3-(3-(Benzyloxy)-4-methoxyphenyl)pyrrolo[2,3-b]pyrrolizin-8(1H)-one | IC50 | 50000.0 [1] |
| 3-(3-Hydroxy-4-methoxyphenyl)pyrrolo[2,3-b]pyrrolizin-8(1H)-one | IC50 | 30000.0 [1] |
| 3-(4-Chlorophenyl)-1H-pyrrolo[2,3-b]pyrrolizin-8-one | IC50 | 50000.0 [1] |